Table 3.
Sex | Total | Male | Female | Male-Female Rate Ratio (95% CI)c |
|||
---|---|---|---|---|---|---|---|
Histology | Count | Rateb | Count | Rate | Count | Rate | |
Ependymoma | 2478 | 0.21 | 1299 | 0.22 | 1179 | 0.19 | 1.15 (1.06–1.24)d |
Pilocytic astrocytoma | 194 | 0.02 | 110 | 0.02 | 84 | 0.02 | 1.28 (0.95–1.72) |
Other astrocytic tumors | 336 | 0.03 | 178 | 0.03 | 158 | 0.03 | 1.15 (0.92–1.43) |
Tumors of spinal nerves | 3125 | 0.26 | 1590 | 0.27 | 1535 | 0.25 | 1.11 (1.04–1.20)d |
Meningioma | 3820 | 0.32 | 723 | 0.13 | 3097 | 0.47 | 0.28 (0.26–0.30)d |
Hemangioblastoma | 269 | 0.02 | 141 | 0.02 | 128 | 0.02 | 1.15 (0.89–1.47) |
Other mesenchymal | 179 | 0.02 | 93 | 0.02 | 86 | 0.01 | 1.14 (0.84–1.55) |
Lymphomas | 306 | 0.03 | 184 | 0.03 | 122 | 0.02 | 1.76 (1.39–2.24)d |
Other | 470 | 0.04 | 243 | 0.04 | 227 | 0.04 | 1.10 (0.91–1.32) |
Unclassified tumors | 535 | 0.04 | 230 | 0.04 | 305 | 0.05 | 0.86 (0.72–1.03) |
Counts pertain to 99.2% of the US population covered by eligible cancer registries. Data from 1 central cancer registry are not included.
Rates are per 100,000 persons and age-adjusted to the 2000 US standard population (19 age groups; Census P25-1130).
Ninety-five percent confidence intervals (CIs) were calculated using the Tiwari modification.
Indicates that the male rate is significantly different from the female rate (P < 0.05) as calculated by the rate ratio.